FDCP
MDT icon

Foster Dykema Cabot & Partners’s Medtronic MDT Stock Holding History

Foster Dykema Cabot & Partners’s Portfolio MDT Stock Details MDT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-797
Closed -$76.5K – 391
2025
Q3 		$76.5K Buy
+797
New +$73.3K 0.01% 190
2024
Q4 		– Sell
-84
Closed -$7.62K – 440
2024
Q3 		$7.62K Buy
+84
New +$7.07K ﹤0.01% 385

Other funds holding MDT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Foster Dykema Cabot & Partners's MDT Position: Q4 2025 in Review

Foster Dykema Cabot & Partners sold out of Medtronic (MDT) in Q4 2025, closing a stake of 797 shares — an estimated $76.5K sold.

Foster Dykema Cabot & Partners first reported a position in MDT in Q3 2024 and held it in 2 quarters. The position peaked at $76.5K in Q3 2025. 2,312 funds tracked by Wall St. Rank hold MDT as of Q4 2025.

  • Foster Dykema Cabot & Partners reported no remaining Medtronic position as of Q4 2025 after selling out during the quarter.
  • Foster Dykema Cabot & Partners sold 797 Medtronic shares in Q4 2025, an estimated $76.5K.
  • Foster Dykema Cabot & Partners first reported a position in Medtronic in Q3 2024 and held it in 2 quarters.
  • Foster Dykema Cabot & Partners's Medtronic position peaked at $76.5K in Q3 2025.
  • 2,312 funds tracked by Wall St. Rank held Medtronic as of Q4 2025.

Based on Foster Dykema Cabot & Partners's 13F filing for Q4 2025, filed 12 Feb 2026.